Do immune checkpoint inhibitors perform identically in patients with weight extremes?

被引:17
作者
El Rassy, Elie [1 ]
Ghosn, Marwan [1 ]
Al Rassy, Nathalie [2 ,3 ]
Assi, Tarek [1 ,4 ]
Robert, Caroline [5 ,6 ]
机构
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Dept Med Oncol, Fac Med, Beirut, Lebanon
[2] Univ Littoral Opal Coast ULCO, Lab Pathophysiol Inflammatory Bone Dis PMOI EA449, Boulogne Sur Mer, France
[3] Univ Lille, Lille, France
[4] Univ Paris Saclay, Inst Gustave Roussy, Dept Med Oncol, F-94805 Villejuif, France
[5] Inst Gustave Roussy, Dept Oncodermatol, 114 Rue Edouard Vaillant, F-94800 Villejuif, France
[6] Univ Paris Sud, 114 Rue Edouard Vaillant, F-94800 Villejuif, France
关键词
anorexia; cachexia; immune checkpoint inhibitors; obesity; BONE-MARROW ADIPOCYTES; BODY-MASS INDEX; CANCER; IMMUNOTHERAPY; OBESITY; ADIPOSITY; BLOCKADE; CELLS;
D O I
10.2217/imt-2018-0053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interaction between the two recent hallmarks of carcinogenesis, the immune system and energetic metabolism, has not been well investigated. The limited literature available on this topic describes a correlation between the efficacy and safety of immune checkpoint inhibitors with body mass index. A key knowledge gap is the understanding of this correlation as outcomes are strongly affected highlighting the need to prospective studies in this regard. This paper evaluates the rationale to these correlations at weight extremes and suggests the evaluation patient's weights and associated inflammatory profile before the initiation of immune checkpoint inhibition in cancer patients.
引用
收藏
页码:733 / 736
页数:4
相关论文
共 27 条
[1]   PDL-1/PD1 inhibitors: antibody or antinobody? [J].
Aoun, Fouad ;
El Rassy, Elie ;
Assi, Tarek ;
Kattan, Joseph .
FUTURE ONCOLOGY, 2017, 13 (19) :1669-1671
[2]   Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults [J].
Bhaskaran, Krishnan ;
Douglas, Ian ;
Forbes, Harriet ;
dos-Santos-Silva, Isabel ;
Leon, David A. ;
Smeeth, Liam .
LANCET, 2014, 384 (9945) :755-765
[3]   Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy [J].
Bouchlaka, Myriam N. ;
Sckisel, Gail D. ;
Chen, Mingyi ;
Mirsoian, Annie ;
Zamora, Anthony E. ;
Maverakis, Emanual ;
Wilkins, Danice E. C. ;
Alderson, Kory L. ;
Hsiao, Hui-Hua ;
Weiss, Jonathan M. ;
Monjazeb, Arta M. ;
Hesdorffer, Charles ;
Ferrucci, Luigi ;
Longo, Dan L. ;
Blazar, Bruce R. ;
Wiltrout, Robert H. ;
Redelman, Doug ;
Taub, Dennis D. ;
Murphy, William J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) :2223-2237
[4]   Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines [J].
Butt, A. Q. ;
Mills, K. H. G. .
ONCOGENE, 2014, 33 (38) :4623-4631
[5]   Altered Distribution and Increased IL-17 Production by Mucosal-Associated Invariant T Cells in Adult and Childhood Obesity [J].
Carolan, Eirin ;
Tobin, Laura M. ;
Mangan, Bozgana A. ;
Corrigan, Michelle ;
Gaoatswe, Gadinthsware ;
Byrne, Greg ;
Geoghegan, Justin ;
Cody, Declan ;
O'Connell, Jean ;
Winter, Desmond C. ;
Doherty, Derek G. ;
Lynch, Lydia ;
O'Shea, Donal ;
Hogan, Andrew E. .
JOURNAL OF IMMUNOLOGY, 2015, 194 (12) :5775-5780
[6]   Obesity-associated cancer: an immunological perspective [J].
Conroy, Melissa J. ;
Dunne, Margaret R. ;
Donohoe, Claire L. ;
Reynolds, John V. .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2016, 75 (02) :125-138
[7]   Obesity Impairs γδT Cell Homeostasis and Antiviral Function in Humans [J].
Costanzo, Anne E. ;
Taylor, Kristen R. ;
Dutt, Shelley ;
Han, Peggy P. ;
Fujioka, Ken ;
Jameson, Julie M. .
PLOS ONE, 2015, 10 (03)
[8]   Caloric Restriction Leads to High Marrow Adiposity and Low Bone Mass in Growing Mice [J].
Devlin, Maureen J. ;
Cloutier, Alison M. ;
Thomas, Nishina A. ;
Panus, David A. ;
Lotinun, Sutada ;
Pinz, Ilka ;
Baron, Roland ;
Rosen, Clifford J. ;
Bouxsein, Mary L. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (09) :2078-2088
[9]   Using macrophage activation to augment immunotherapy of established tumours [J].
Fridlender, Z. G. ;
Jassar, A. ;
Mishalian, I. ;
Wang, L-C S. ;
Kapoor, V. ;
Cheng, G. ;
Sun, J. ;
Singhal, S. ;
Levy, L. ;
Albelda, S. M. .
BRITISH JOURNAL OF CANCER, 2013, 108 (06) :1288-1297
[10]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70